Insulin Pens Market Size, Share, Growth Industry Analysis and Forecast 2027
According to The Insight Partners market research study titled "Insulin Pens Market - Global Analysis and Forecasts by product type, application and distribution channel". The global insulin pens market is expected to reach US$ 8,862.0 Mn in 2027 from US$ 4,199.7 in 2018. The market is estimated to grow with a CAGR of 8.8% from 2019-2027. The report highlights trend prevalent in the global insulin pens market and the factors driving the market along with those that act as deterrents to its growth.
Insulin pens are devices used for the diabetes patients to inject the insulin in the patient’s body in desired quantity. The insulin pen is slightly larger than the writing pen in size and it contains the insulin in the refill. Insulin pens have made it convenient and less painful for the diabetic patients to take insulin. Not only insulin pen injects precise amount of insulin in the body but also it may be done in fewer steps than syringe. Driving factors such as, rising incidence of diabetes, growing geriatric population, inclination towards insulin pens over conventional needles & syringes in insulin pens are expected to boost the market growth over the years. However, alternatives to pens for insulin administration and limitation associated with the insulin pens are likely to hamper the market growth. However, growing market in developing regions are likely to deliver substantial growth opportunities to improve market share for industry players in the near future.
Get sample Research Pages of Insulin Pens Market study at: https://www.theinsightpartners.com/sample/TIPRE00004650/
Insulin Pens Market Competitive Landscape and Key Development
Some of the prominent players operating in insulin pens market are, Novo Nordisk A/S, Owen Mumford, Sanofi, Ypsomed AG, Biocon, Companion Medical, BERLIN CHEMIE AG, Eli Lilly and Company, pendiq, and Emperra GmbH E-Health Technologies among others. The market players are focused on bringing new and innovative products and services to sustain their position in the market. For instance, in June 2016, Haselmeier announced the German launch of the BerliPen areo 3 through BERLIN CHEMIE AG. Key features of this third-generation BerliPen are an optimized dose indicator, the innovative low-friction mechanism for smooth injection release in addition to an enhanced feeling of safety utilizing audible and tactile dose settings.
Rising incidence of diabetes
Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipidus and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries up to 91% of adults with the disease have type 2 diabetes.
According to International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in 2017 and it is expected to reach 629 million by 2045 across the globe. Additionally, according to BMJ Open Diabetes Research & Care, approximately 387 million patients across the globe suffer with diabetes, out of which 5-10% are victims of type-1 diabetes that require regular insulin doses. Patients suffering from diabetes require frequent monitoring and external administration of insulin that is given through insulin pens and other medical devices. The rising prevalence of diabetes across the globe is expected to drive the growth of the insulin pens market worldwide during the forecast period.
The key factors that are driving the growth of the market are rising incidence of diabetes, growing geriatric population, and increasing adoption of insulin pens over conventional vials and syringes. However, the factors restraining the market growth are the high cost of insulin pens and the availability of alternatives to insulin pens in the market. On the other hand, the high potential of market growth in the emerging economies is one of the growth opportunities for market players. In recent years, there has been considerable development in the field of medical drug delivery devices. Insulin administration is a common procedure in the diabetic population. Traditional insulin syringes have several disadvantages that include the experience of pain by patients due to repeated pricks, discomfort in carrying both insulin bottle as well as syringe, risk of needle re-use associated infections and needle-stick injuries as well as difficulty in delivering a mixture of two or more liquids together in one syringe. Additionally, self-administration of insulin through syringes and vials is time-taking and difficult that has reduced the adoption of conventional insulin injection methods over the past years and led to increased adoption of injection pens.
Insulin Pens Market: Segmental Overview
The global insulin pens market, based on product type is segmented into reusable, disposable, and smart insulin pen caps. In 2018, the reusable segment held the largest share of the market, by product type. This is attributed advanced features that make reusable insulin pens safe and convenient, ease of use and the ability to deliver highly accurate doses. Moreover, the smart insulin pen caps segment of insulin pens market is expected to witness growth in its demand at a fastest CAGR of 9.9% during 2019 to 2027.
The global insulin pens market, based on application is segmented into type-1 diabetes and type-2 diabetes. In 2018, the type-1 diabetes segment held the largest share of the market, by application. Moreover, the type-1 diabetes segment of insulin pens market is also expected to witness growth in its demand at a fastest CAGR of 9.1% during 2019 to 2027. The dominance and growth of the diabetes type-1 segment attributes to requirement of these devices predominantly among type-1 diabetes patients and ease of insulin delivery faced by these patients with the use of these pens.
Buy Complete Report of Insulin Pens Market Study at: https://www.theinsightpartners.com/buy/TIPRE00004650/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
Contact Person: Sameer Joshi